Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by wilson disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 2, 2014, Pages 160-164

  Rustom, Najla ^a   Bost, Muriel ^b   Cour Andlauer, Fleur ^a   Lachaux, Alain ^a   Brunet, Anne Sophie ^a   Boillot, Olivier ^b   Bordet, Fabienne ^a   Valla, Frederic ^a   Richard, Nathalie ^a   Javouhey, Etienne ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

acute liver failure; albumin dialysis; artificial liver support; molecular adsorbents and recirculating system; Wilson disease

Indexed keywords

ALBUMINOID; AMMONIA; BILIRUBIN; COPPER; CREATININE;

ACUTE KIDNEY INJURY; ADOLESCENT; ADSORPTION; BLOOD; CHILD; COMPLICATION; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOLENTICULAR DEGENERATION; HUMAN; LIVER; LIVER FAILURE, ACUTE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; METABOLISM; PATHOLOGY; PROCEDURES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; ADOLESCENT; ADSORPTION; ALBUMINS; AMMONIA; BILIRUBIN; CHILD; COPPER; CREATININE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84894200603     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182a853a3     Document Type: Article

References (21)

1. Bull PC, Thomas GR, Rommens JM, et al. The Wilson's disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993:327-37.
2. Sternlieb I, Scheinberg IH. Wilson's disease. In: Schiff L, Schiff ER, eds. Diseases of the Liver. 7th ed. Philadelphia: J.B. Lippincott; 1993: 659-68.
3. Walshe JM. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of 87 patients. Q J Med 1989;263:253-63.
4. Roche-Sicot J, Benhamou JP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med 1977;86:301-3.
5. Hamlyn AN, Gollan JL, Douglas AP, et al. Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. Br Med J 1977;2:660-2.
6. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994;19:583-7.
7. Dhawan A, Taylor RM, Cheeseman P, et al. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transplantat 2005;11:441-8.
8. Roberts EA, Schilsky ML. A practical guideline on Wilson disease. Hepatology 2003;37:1475-92.
9. Mitzner S, Klammt S, Stange J, et al. Albumin regeneration in liver support-comparisonofdifferent methods. Ther Apher Dial 2006;10:108-17.
10. Collins C, Roberts E, Adeli K, et al. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol 2008;23:1013-6.
11. Kreymann B, Seige M, Schweigart U, et al. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-5.
12. Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculatiig system (MARS) for acute Wilson's disease. Liver Transplantat 2002;8:962-7.
13. Stange J, Mitzner SR, Rislet T, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23:319-30.
14. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277-86.
15. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-58.
16. Hassanein TI, Tofteng F, Brown RS Jr et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-62.
17. Parés A, Deulofeu R, Cisneros L, et al. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 2009;13:1-8.
18. Schmidt LE, Tofteng F, Strauss GI, et al. Effect of treatment with the molecular adsorbents recirculating system on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalo-pathy. Scand J Gastroenterol 2004;39:974-80.
19. Blei AT, Olafsson S, Webster S, et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;34:157-8.
20. Wauters J, Wilmer A. Albumin dialysis: current practice and future options. Liver Int 2011;31 (suppl 3):9-12.
21. Manz T, Ochs A, Bisse E, et al. Liver support-a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Blood Purif 2003;21:232-6.